Management of venous thrombosis and pulmonary embolism after gynecological surgery

Seminars in Thrombosis and Hemostasis

Volumn 24, Issue 5, 1998, Pages 437-442

  Adachi, Tomoko ^a   Nakabayashi, Masao ^a   Takeda, Yoshihiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Deep venous thrombosis; Gynecological surgery; Pulmonary embolism; Risk factors of thrombosis

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; NAFAMSTAT; NAFAMSTAT MESILATE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; ANTICOAGULANT THERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; FEMALE; FIBRINOLYTIC THERAPY; GYNECOLOGIC SURGERY; HUMAN; LEG EXERCISE; LUNG EMBOLISM; PHYSICAL EXAMINATION; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT; VEIN THROMBOSIS;

EID: 0031758674     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996036     Document Type: Conference Paper

References (15)

1. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975;17:259-270
2. LeQuesne LP. Relation between deep vein thrombosis and pulmonary embolism in surgical patients. N Engl J Med 1974; 291:1292-1294
3. Saito H. Thrombophilia. Gendaiiryou (in Japanese) 1992;24: 3123-3125
4. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990; 74:1-9
5. Broekmans AW, Veltkamp JJ. Congenital protein C deficiency and venous thromboembolism. N Engl J Med 1983;309:340-344
6. Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984;311:1525-1528
7. Strandness DE Jr, Ward K, Krugmire R Jr. The present status of acute deep venous thrombosis. Surg Gynecol Obstet 1977;145: 433-445
8. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes and management. Blood 1996;87:3531-3544
9. Halbmayer WM, Haushover A, Schön R, Fischer M. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coag Fibrinolysis 1994;5:51-57
10. Bergan JJ, Yao JST (eds). Venous Complications. Chicago: Year Book, 1978
11. Kakkar VV. Effectiveness and safety of low molecular weight heparins (LMWH) in the prevention of venous thromboembolism (VTE). Thromb Haemostas 1995;74:364-368
12. Nakano T, Hiraoka N, Fujioka H. Treatment of pulmonary embolism. J Jpn Coll Angiol (in Japanese), 1993;33:429-435
13. Meyer G, Sors H, Charbonnier B, et al. The effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism. A European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism. J Am Coll Cardiol 1992;19:239-245
14. Goldhaber SZ, Vaughan DE, Markis JE, et al. Acute pulmonary embolism treated with tissue plasminogen activator. Lancet 1986;2:886-889
15. Greenfield LJ. Pulmonary embolectomy and vena caval interruption. In: Bergan JJ, Yao JST (eds), Vascular Surgical Emergencies. Orlando: Grune & Stratum; 1987; 453-460